Goldman Sachs’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Goldman Sachs’s Portfolio CRCD Stock Details CRCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$391K	Buy	+55,972	New	+$263K	﹤0.01%	5849

Other funds holding CRCD

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Goldman Sachs's CRCD Position: Q2 2026 in Review

Goldman Sachs opened a new position in T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q2 2026: 55,972 shares worth $391K. The stake represents ﹤0.01% of the portfolio and ranks #5849 among its holdings.

12 funds tracked by Wall St. Rank hold CRCD as of Q2 2026.

Goldman Sachs held 55,972 shares of T-REX 2X Inverse CRCL Daily Target ETF worth $391K as of Q2 2026.
T-REX 2X Inverse CRCL Daily Target ETF was a new Goldman Sachs position in Q2 2026.
T-REX 2X Inverse CRCL Daily Target ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5849 holding.
12 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.